The Latest Breaking News from AIZ

Assurant is all set to release its fiscal first-quarter earnings next month, and analysts project a double-digit profit decline.

Despite Assurant's underperformance relative to the financial sector, Wall Street analysts remain moderately optimistic about the stock’s prospects.

With Assurant gearing up to release its third-quarter earnings next month, analysts expect a double-digit earnings decline.

Despite Assurant’s underperformance relative to the Nasdaq Composite over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.

Assurant has outperformed the broader market over the past year, and Wall Street analysts are moderately optimistic about the stock’s prospects.

Assurant is poised to announce its second-quarter results next month, and analysts forecast a marginal decline in the company’s bottom-line figure.

Despite lingering macroeconomic headwinds, the broader market has shown remarkable fortitude this year and is poised for an even greater surge ahead. Hence, it could be wise to invest in fundamentally sound stocks Assurant (AIZ), ACADIA Pharmaceuticals (ACAD), and Accel Entertainment (ACEL), which have gained significant momentum lately. Continue reading….

Jim Cramer, the host of CNBC’s “Mad Money,” affirmed a positive outlook on Assurant (AIZ) stock due to low volatility and solid fundamentals. Given the fluctuating market trends, investing in a stable stock like AIZ could be rewarding. Read on.

The U.S. equity market has experienced elevated volatility lately amid record-high inflation, increased possibility of the Fed’s drastic interest rate increases to bring price stability, and growing recession fears. As the U.S. economy is slowly sliding into a recession, fundamentally strong consumer discretionary stocks UnitedHealth (UNH), Assurant (AIZ), Pilgrim’s Pride…